ABP Stock Analysis: Buy, Sell, or Hold?
ABP - Abpro Holdings, Inc Common Stock
$1.90
-0.02 (-1.04%)
▼
5d:
-6.13%
30d:
-54.98%
90d:
-65.24%
HOLD
LOW Confidence
Last Updated: February 3, 2026
Get Alerted When ABP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABP is currently trading at $1.90, which is considered oversold relative to its 30-day fair value range of $2.43 to $4.33.
Technical Outlook: Technically, ABP is in a strong downtrend. Immediate support is located at $1.80, while resistance sits at $3.33.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABP is in a strong downtrend. Immediate support is located at $1.80, while resistance sits at $3.33.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.43 -
$4.33
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($2.00)
- CAUTION: Recommendation downgraded due to -6.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.43 -
$4.33
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.80
Resistance Level
$3.33
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.28
Wall Street Target
$2.00
(+4.2%)
Revenue Growth (YoY)
-100.0%
Last updated: February 03, 2026 2:55 PM ET
Data refreshes hourly during market hours. Next update: 3:55 PM
Data refreshes hourly during market hours. Next update: 3:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 67 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 65 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |